Fujian Aonong Biological Technology Group Incorporation Gestione

Gestione criteri di controllo 3/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

You Lin Wu

Amministratore delegato

CN¥625.7k

Compenso totale

Percentuale dello stipendio del CEO	n/a
Mandato del CEO	9.2yrs
Proprietà del CEO	8.7%
Durata media del management	less than a year
Durata media del Consiglio di amministrazione	3yrs

Aggiornamenti recenti sulla gestione

Recent updates

AMMINISTRATORE DELEGATO

You Lin Wu (46 yo)

9.2yrs

Mandato

CN¥625,700

Compensazione

Mr. You Lin Wu serves as the Chairman of the Board of Directors and General Manager at Fujian Aonong Biological Technology Group Incorporation Limited and has been its Director since August 27, 2015. Mr. W...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
You Lin Wu	Chairman of the Board of Directors & GM	no data	CN¥625.70k	8.67% CN¥ 256.4m
Qiang Lin	Deputy GM	less than a year	Nessun dato	Nessun dato
Jun Guo	Deputy GM & GM of Capital Management Centre	less than a year	Nessun dato	Nessun dato
Jingquan Yang	Deputy General Manager	3yrs	CN¥598.30k	0.016% CN¥ 486.2k
Jianping Yang	Accounting Supervisor	no data	Nessun dato	Nessun dato

0.8yrs

Durata media

45.5yo

Età media

Gestione esperta: Il team dirigenziale di 603363 non è considerato esperto (durata media 0.8 anni), il che suggerisce un nuovo team.

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
You Lin Wu	Chairman of the Board of Directors & GM	9.2yrs	CN¥625.70k	8.67% CN¥ 256.4m
Feng Liu	Independent Director	3yrs	CN¥120.00k	0.0033% CN¥ 97.3k
Luying Zheng	Independent Director	3yrs	CN¥120.00k	Nessun dato
Chunxiang Ai	Independent Director	3yrs	CN¥120.00k	Nessun dato
Jun Kuang	Director	less than a year	CN¥485.10k	Nessun dato
Zhirong Lian	Supervisor	less than a year	Nessun dato	0.0026% CN¥ 76.6k

3.0yrs

Durata media

46yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di 603363 sono considerati esperti (durata media dell'incarico 3 anni).

Fujian Aonong Biological Technology Group Incorporation Gestione

Gestione criteri di controllo 3/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Fujian Aonong Biological Technology Group Incorporation Limited, Annual General Meeting, Jun 06, 2024

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Third quarter 2024 earnings released: CN¥0.32 loss per share (vs CN¥0.56 loss in 3Q 2023)

Fujian Aonong Biological Technology Group Incorporation Limited to Report Q3, 2024 Results on Oct 31, 2024

Second quarter 2024 earnings released: CN¥0.28 loss per share (vs CN¥0.71 loss in 2Q 2023)

Fujian Aonong Biological Technology Group Incorporation Limited to Report First Half, 2024 Results on Aug 31, 2024

Fujian Aonong Biological Technology Group Incorporation Limited, Annual General Meeting, Jun 06, 2024

Less than half of directors are independent

Fujian Aonong Biological Technology Group Incorporation Limited to Report Q1, 2024 Results on Apr 30, 2024

New minor risk - Share price stability

Fujian Aonong Biological Technology Group Incorporation Limited to Report Fiscal Year 2023 Results on Apr 30, 2024

Third quarter 2023 earnings released: CN¥0.56 loss per share (vs CN¥0.12 profit in 3Q 2022)

Second quarter 2023 earnings released: CN¥0.71 loss per share (vs CN¥0.42 loss in 2Q 2022)

First quarter 2023 earnings released: CN¥0.21 loss per share (vs CN¥0.54 loss in 1Q 2022)

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.12 (vs CN¥0.50 loss in 3Q 2021)

Now 20% undervalued after recent price drop

First quarter 2022 earnings released: CN¥0.54 loss per share (vs CN¥0.25 profit in 1Q 2021)

Less than half of directors are independent

Third quarter 2021 earnings released: CN¥0.50 loss per share (vs CN¥0.25 profit in 3Q 2020)

Second quarter 2021 earnings released: CN¥0.54 loss per share (vs CN¥0.33 profit in 2Q 2020)

First quarter 2021 earnings released: EPS CN¥0.25 (vs CN¥0.27 in 1Q 2020)

Full year 2020 earnings released: EPS CN¥0.95 (vs CN¥0.054 in FY 2019)

Investor sentiment improved over the past week

New 90-day high: CN¥15.51

Investor sentiment improved over the past week

New 90-day low: CN¥12.37

New 90-day low: CN¥13.15

New 90-day low: CN¥13.54

Fujian Aonong Biological Technology Group Incorporation Limited to Report Q3, 2020 Results on Oct 31, 2020

New 90-day low: CN¥13.63

Liu Xueke, Su Guoyang, Wu Boyuan, and Liu Lianlong agreed to acquire 21% stake in Xiamen Aomu Trade Co., Ltd from Fujian Aonong Biological Technology Group Incorporation Limited (SHSE:603363) for CNY 0.

New 90-day low - CN¥20.10

Fujian Aonong Biological Technology Group Incorporation Limited (SHSE:603363) completed the acquisition of the remaining 70% stake in Xiamen Yinxiang Meat Industry Co., Ltd. from Xiamen Yinxiang Group Co., Ltd.

New 90-day high - CN¥26.31

Earnings released

Fujian Aonong Biological Technology Group Incorporation Limited to Report First Half, 2020 Results on Aug 20, 2020

AMMINISTRATORE DELEGATO

Mandato

Compensazione

Gruppo dirigente

Durata media

Età media

Membri del Consiglio di amministrazione

Durata media

Età media